Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price
₹272.05
Market cap
₹3,046 Cr
Revenue (annual)
₹745.8 Cr
Net profit (annual)
₹168.7 Cr
P/E (TTM)
18.4×Sector 47.4×
Promoter holding
43.24%-0.02% QoQ
FII holding
26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 28Earnings Call 6Other Announcement 3Financial Results 3Board Meeting Date 3Results Update 2Promoter Reclassification 2Merger & Restructuring 2Management Change 2Dividend 2Board Meeting Outcome 2Annual General Meeting 2Fund Raise 1Employee Stock Options 1Credit Rating 1Business Update 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

3 announcements with these filters

18:31 IST BSE
Other Announcement

Advanced Enzyme Technologies Other Announcement

Advanced Enzyme Technologies Ltd bought back 68,248 equity shares on August 27, 2026, at an average price of ₹298.11, totaling approximately ₹2.03 Crore.

Value
₹2.03 Cr
Read the filing ↗
17:05 IST BSE
Other Announcement

Advanced Enzyme Technologies Other Announcement

Advanced Enzyme Technologies filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulations.

Read the filing ↗
18:23 IST BSE
Other Announcement

Advanced Enzyme Technologies Other Announcement

Advanced Enzyme Technologies filed its Annual Secretarial Compliance Report for FY2026. The auditor confirmed full compliance with SEBI regulations with no adverse observations reported.

Read the filing ↗